CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Trius Therapeutics

For profitContributed to NME

Also known as: Tris Pharma | Trius

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 11, 2017

Acquired by Cubist → Merck on Sep 11, 2013

Timeline

2000s

Jul 1, 2004
Trius Therapeutics— Founded

2010s

Sep 11, 2013
Cubist— Acquired By
Dec 8, 2014
Merck— Now

Drugs by trial phase (5 distinct, 19 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (30)

NCT03088267Study chairPhase 3Feb 11, 2017
NCT01623401Study chairPhase 1May 1, 2012
NCT01623401Lead sponsorPhase 1May 1, 2012
NCT01577459Lead sponsorPhase 1Apr 1, 2012
NCT01577459Study chairPhase 1Apr 1, 2012
NCT01539473Study chairPhase 1Feb 1, 2012
NCT01539473Lead sponsorPhase 1Feb 1, 2012
NCT01519778Study chairPhase 2Feb 1, 2012
NCT01519778Lead sponsorPhase 2Feb 1, 2012
NCT01496677Study chairPhase 1Dec 1, 2011
NCT01496677Lead sponsorPhase 1Dec 1, 2011
NCT01461460Study chairPhase 1Nov 1, 2011
NCT01461460Lead sponsorPhase 1Nov 1, 2011
NCT01452828Study chairPhase 1Oct 1, 2011
NCT01452828Lead sponsorPhase 1Oct 1, 2011

Details

Founded: San Diego, CA, US Jul 1, 2004
Last known activity: Feb 11, 2017